The clinical effects of prolonged treatment of patients with advanced cancer with low-dose subcutaneous interleukin-2 [corrected]
about
Overexpression of EpCAM in uterine serous papillary carcinoma: implications for EpCAM-specific immunotherapy with human monoclonal antibody adecatumumab (MT201).Immunotherapy for renal carcinoma: theoretical basis and current standard of care.Ontogeny and expansion of human natural killer cells: clinical implications.A randomised study with subcutaneous low-dose interleukin 2 alone vs interleukin 2 plus the pineal neurohormone melatonin in advanced solid neoplasms other than renal cancer and melanoma.Subcutaneous low-dose recombinant interleukin 2 and alpha-interferon in patients with metastatic renal cell carcinoma.A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part I: Clinical aspects.Immunological effects of alternative weekly interferon-alpha-2b and low dose interleukin-2 in patients with cancer.Prolonged immunostimulatory effect of low-dose polyethylene glycol interleukin 2 in patients with human immunodeficiency virus type 1 infection.Interleukin-2 in cancer treatment: disappointing or (still) promising? A review.Prolonged low dose IL-2 and thalidomide in progressive metastatic renal cell carcinoma with concurrent radiotherapy to bone and/or soft tissue metastasis: a phase II study.
P2860
Q33590557-ED2472B0-7F69-4CDE-998A-8E9758E0C340Q34117171-D8856EDA-EDD5-4000-BB2F-F78AE2B3409BQ34552167-82BC22C6-6703-46FD-8476-A4A75E9AD7AAQ35978082-39C7B9CD-F06F-4333-8BE1-63AF03A69F43Q35979169-B33913C0-EA37-4A90-844B-75C28C8BFB1FQ35993098-E925F7AE-60F5-489E-87DA-824C43B21FBBQ35994573-7AB28876-E851-473F-B7B3-71CF2E725E5AQ36361254-3C318B57-8692-4817-9D1B-8B47753B0328Q39232767-B25895DE-6DC5-4500-A022-79BA61FDB46FQ46500327-45A37D74-6C75-4DB0-BAEE-8C36E86D917D
P2860
The clinical effects of prolonged treatment of patients with advanced cancer with low-dose subcutaneous interleukin-2 [corrected]
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
The clinical effects of prolon ...... eous interleukin-2 [corrected]
@ast
The clinical effects of prolon ...... eous interleukin-2 [corrected]
@en
type
label
The clinical effects of prolon ...... eous interleukin-2 [corrected]
@ast
The clinical effects of prolon ...... eous interleukin-2 [corrected]
@en
prefLabel
The clinical effects of prolon ...... eous interleukin-2 [corrected]
@ast
The clinical effects of prolon ...... eous interleukin-2 [corrected]
@en
P2093
P2860
P356
P1476
The clinical effects of prolon ...... eous interleukin-2 [corrected]
@en
P2093
Aniszewski C
Gordon-Smith EC
Malkovska V
Marsden RA
Shearer RJ
P2860
P2888
P304
P356
10.1038/BJC.1991.64
P407
P577
1991-02-01T00:00:00Z
P5875
P6179
1052803700